HOME >> MEDICINE >> NEWS
Scientists stalk PPAR-gamma, find novel cancer connection

In laboratory tests on multiple myeloma cells, University of Rochester researchers found that this type of cancer expresses a protein that makes it an easy target for an existing class of diabetes drugs. After more investigation, they hope the discovery will lead to a new, targeted therapy for myeloma patients.

"To our knowledge, this is the first time anyone has shown that multiple myeloma cells are sensitive to these agents, and we found multiple myeloma cells are killed quite effectively," says lead author Richard P. Phipps, Ph.D., professor of Environmental Medicine and of Oncology at the University of Rochester Medical Center.

The research was reported in the November issue of Clinical Immunology.

The drugs in question are from the thiazolidinedione (TZD) class of anti-diabetic therapies, known as PPAR-gamma ligands. They bind to PPAR-gamma, a protein associated with multiple myeloma and many other cancers, as well as chronic inflammation and diabetes. When the drugs bind to PPAR-gamma, at least in laboratory experiments, the cancerous cells are destroyed.

PPAR-ligands are emerging as a new type of cancer therapy because they directly target errant cells and stop tumor growth, at least in animal models. Phipps' laboratory also found that the PPAR-ligands currently used in anti-diabetic drugs could induce a type of cell death called apoptosis. This is significant because multiple myeloma is very difficult to treat, as it is usually resistant to drug-induced apoptosis.

Another encouraging factor is that the anti-diabetes drugs were able to kill the multiple myeloma cells, despite the fact that myeloma produces its own growth factor (Interleukin 6), which usually enables the cancer to multiply more effectively. Furthermore, the Phipps lab found that the effectiveness of the TZD drugs was enhanced when combined with Vitamin A-like compounds.

Co-investigator Steven Bernstein, M.D., who treat
'"/>

Contact: Leslie Orr
leslie_orr@urmc.rochester.edu
585-275-5774
University of Rochester Medical Center
8-Dec-2004


Page: 1 2

Related medicine news :

1. Scientists replicate hepatitis C virus in laboratory
2. Scientists identify brain regions that decide where we look
3. Scientists uncover new mechanism for the amygdala in fear recognition
4. Scientists identify protein critical to melanoma growth
5. Scientists discover recipe for life: eating the Polymeal cuts heart disease by 76%
6. Scientists study fish oil diet in bid to cut heart attack risks
7. Scientists discover enzyme crucial to the transportation of proteins within cells
8. Scientists turn on the gender lens on cardiovascular disease research
9. Scientists align billion-year-old protein with embryonic heart defects
10. Scientists pinpoint flaw, offer new promise for stroke treatment
11. Scientists discover enzyme crucial to HIV replication

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/10/2018)... BOISE, Idaho (PRWEB) , ... December 10, 2018 , ... Five years ago, Erica Lester ... married to a darling man who loved me to pieces. I had two beautiful daughters. ... But inside, I was miserable.” , Lester says she spent most days struggling to ...
(Date:12/8/2018)... ... December 07, 2018 , ... “The ... juncture in world affairs, U.S. leadership and funding at the United Nations matters. ... strides in reducing extreme poverty and advancing global health plus meaningful reforms in ...
(Date:12/6/2018)... ... December 06, 2018 , ... We all know ... are alternative solutions. M.D.-formulated Relaxium Calm is a dietary supplement developed to promote ... Sensoril®, an extract of the ashwagandha root. Ashwagandha is a powerful herb that ...
(Date:12/5/2018)... ... December 05, 2018 , ... ... of the first plastic surgery practices in Houston to offer the BodyTitePRO treatment. ... his patients an innovative range of surgical and noninvasive techniques to improve the ...
(Date:12/5/2018)... ... December 05, 2018 , ... Advanced ... Consulting services, announced its new office location in Paris, France during the Partnerships ... clinical trial operations in Europe and additional in-country personnel. , “The new office ...
Breaking Medicine News(10 mins):
(Date:11/29/2018)... Fla. (PRWEB) , ... November 29, 2018 , ... ... practitioner-channel dietary supplement company – announced today the launch of the Annatto-E™ product ... annatto plant (Bixa orellana). Backed by clinical research, DFH’s new Annatto-E™ products are ...
(Date:11/29/2018)... , ... November 29, 2018 , ... ... This unique product makes the company’s powerful electronic forms and eSignatures functionality accessible ... progress by leaps and bounds in the consumer space and it’s about time ...
(Date:11/28/2018)... Israel (PRWEB) , ... November 28, 2018 , ... ... is traveling to Israel’s Sheba Medical Center, Tel HaShomer this week to form ... hospital in his home country, the Democratic Republic of Congo. , On ...
Breaking Medicine Technology:
Cached News: